Feature Articles
Treatment of Multiple Sclerosis Relapses
Living With Multiple Sclerosis Disease Progression
NARCOMS Report-Relapse Management

Denise I. Campagnolo, MD, MS, Director Clinical Multiple Sclerosis Research, Barrow Neurological Institute, Phoenix,
Arizona; Timothy L.Vollmer, MD, VanDenburgh Fellow, Director BNI Neuroimmunology Program, Barrow Neurological
Institute, Phoenix, Arizona
Key Words:
Antigens – Any substance that provokes an immune response. Ideally, the antigen is a foreign substance, like a protein made by a bacterium. Sometimes T cells inappropriately react [...]

Elizabeth Auld, PA- C––Spinal Cord Program, MSCS,VA Connecticut Healthcare System,West Haven, Connecticut
Introduction
Research into what is happening to the central nervous system in multiple sclerosis (MS) gives hope that the disease can be slowed and eventually cured or prevented. Realistically, persons with MS understand that until there is a cure, they will have to accept and [...]

Tuula Tyry PhD, MAEd—Program and Editorial Manager, Barrow Neurological Institute, Phoenix, Arizona
Introduction
A relapsing-remitting disease course is typical in most cases of multiple sclerosis (MS), especially during its early stages. Optimal treatment of each relapse (or exacerbation) depends on its severity and other factors as described in the lead article in this issue (see pages 6 [...]